A combined analysis of two landmark clinical glaucoma trials — the Ocular Hypertension Treatment Study (OHTS) and the European Glaucoma Prevention Study (EGPS) — confirms the benefit of a five-year risk assessment model to help ophthalmologists better predict which patients have an increased risk of developing glaucoma. Glaucoma is the second leading cause of blindness in the world, affecting approximately 70 million people, and can lead to blindness if left untreated. These new data were presented this week at the annual American Academy of Ophthalmology meeting.
Dilated eye exams, in which special eye drops are used to widen the pupils, allow eye care professionals to see into the back of the eye to check for early signs of eye disease such as glaucoma and diabetic retinopathy, two of the leading causes of blindness in this country. But many people, particularly seniors who are at increased risk for these diseases, do not get this important test.
Infants and adults who are blind due to a cloudy or damaged cornea are seeing some remarkable results thanks to a new version of an artificial implant that takes the place of the cornea, the clear covering of the eye that serves as our window on the world.
Volunteers for a study on the degenerative eye disease, glaucoma, and its link with falls in older people are being sought by a Queensland University of Technology optometry researcher.
New data suggest that Strattera? (atomoxetine HCl) improved ADHD symptoms in children and adolescents who had both ADHD and a reading disorder, like dyslexia. Results were announced at a meeting of child and adolescent psychiatrists.
Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced that its Attention Deficit Hyperactivity Disorder (ADHD) patch, DAYTRANA tm (methylphenidate transdermal system), has significant efficacy in reducing the symptoms of ADHD in children aged 6 to 12 years, even when the ADHD patch is taken off earlier than the recommended nine hours. The ability to remove the patch earlier than the recommended nine-hour wear time allows physicians the opportunity to manage the potential for late-day side effects, such as lack of appetite or difficulty sleeping. These phase IIIb clinical trial results were reported today at a major scientific and educational meeting of child and adolescent psychiatrists in San Diego, Calif.
A new study shows having high blood pressure can not only raise your risk of having a heart attacks or stroke, it can also lead to glaucoma, a leading cause of blindness.
Over a romantic candlelit dinner, the eyes may be the windows to the soul. In a more prosaic light, they’re windows to the heart, according to the March issue of the Harvard Heart Letter. A look into the eye can reveal the silent damage wrought by high blood pressure and diabetes and reflect the risk of a future stroke or heart attack.
Latinos living in the United States have high rates of eye
disease and visual impairment, according to a research
study, and a significant number may be unaware of their eye
disease. This study, called the Los Angeles Latino Eye
Study (LALES), is the largest, most comprehensive
epidemiological analysis of visual impairment in Latinos
conducted in the U.S.
I have a few cases of retinal detachment running into the OPD of our hospital. I have seen a marvelous role of Naphthalinum in this line. The potency most frequently used in these cases is 3x, the next one being 30c. some other remedies of choice have been Digitalis, Aur met, Jaborandi and Ruta. To understand it well, we should make a study on retinal detachment first.